Retour sur lavenir.net
   RECTICEL 10.480 € (+0,96 %)     SIPEF 100.400 € (-0,99 %)     SOLVAY 26.180 € (-9,29 %)     AB INBEV 68.060 € (-3,27 %)     ONWARD MEDICAL 2.680 € (-0,74 %)     KINEPOLIS GROUP 30.600 € (+0,82 %)     UCB 237.300 € (+0,55 %)     BARCO 9.175 € (-0,16 %)     KBC 117.100 € (+0,90 %)     BIOTALYS 2.910 € (-2,35 %)     AEDIFICA 72.000 € (-1,03 %)     BREDERODE 102.400 € (-0,58 %)     AGEAS 67.300 € (0,00 %)     SOFINA 222.000 € (-1,07 %)     ARGENX SE 700.000 € (+1,69 %)     SYENSQO 57.050 € (-2,98 %)     D'IETEREN GROUP 184.900 € (+0,49 %)     VAN DE VELDE 31.200 € (-5,17 %)     UMICORE 21.480 € (+3,37 %)     DECEUNINCK 2.060 € (0,00 %)     ECONOCOM GROUP 1.410 € (+0,71 %)     WDP 22.580 € (-0,18 %)     MELEXIS 76.450 € (-0,33 %)     MONTEA 70.300 € (-0,71 %)     ACKERMANS V.HAAREN 296.200 € (-0,07 %)     KBC ANCORA 81.000 € (+1,25 %)     XIOR 27.850 € (+0,54 %)     GBL 82.000 € (-0,24 %)     NYXOAH 2.705 € (-0,37 %)     TUBIZE-FIN 202.200 € (-0,10 %)     WHAT'S COOKING GP 143.500 € (0,00 %)     CIE BOIS SAUVAGE 326.500 € (+0,15 %)     CMB.TECH 12.500 € (-1,11 %)     ELIA GROUP 136.600 € (-1,94 %)     FAGRON 24.800 € (-0,20 %)     SHURGARD 26.150 € (+0,19 %)     RETAIL ESTATES 67.600 € (-0,73 %)     TESSENDERLO 21.900 € (+0,92 %)     VGP 90.600 € (+0,33 %)     BEKAERT 44.150 € (+0,34 %)     PROXIMUS 6.585 € (-0,30 %)     GIMV 48.400 € (-0,41 %)     AZELIS GROUP 10.630 € (-1,57 %)     OPTION 6.020 € (-1,63 %)     CAMPINE 224.000 € (-1,75 %)     EXMAR 10.800 € (-0,46 %)     TITAN S.A. 51.200 € (+3,64 %)     CELYAD ONCOLOGY 0.310 € (-2,52 %)     ONTEX GROUP 2.900 € (+0,17 %)     COFINIMMO 84.850 € (-0,64 %)     HOME INVEST BE. 19.320 € (-0,31 %)     DEME GROUP 205.000 € (+0,74 %)     BPOST 1.666 € (-2,00 %)     LOTUS BAKERIES 10 860.000 € (+1,12 %)     FLUXYS BELGIUM D 22.100 € (-2,21 %)     KEYWARE TECH. 0.970 € (0,00 %)     ATENOR 1.695 € (+0,89 %)     CARE PROPERTY INV. 13.160 € (+0,46 %)     WERELDHAVE BELGIUM 53.600 € (+0,37 %)     VIOHALCO 17.580 € (+1,27 %)  
   OPMOBILITY 15.650 € (+1,03 %)     LOUIS HACHETTE 1.598 € (-3,15 %)     FDJ UNITED 22.980 € (0,00 %)     VIRIDIEN 118.000 € (-1,17 %)     EMEIS 15.380 € (+0,59 %)     CVC CAPITAL 13.590 € (+0,37 %)     KLEA HOLDING 0.186 € (-0,96 %)     ODYSSEE TECHNO 21.700 € (+1,88 %)     STIF 51.000 € (-0,97 %)     J.MARTINS,SGPS 20.580 € (+3,78 %)     SOITEC 152.350 € (+3,75 %)     UMG 19.215 € (+0,34 %)     AVANTIUM 8.370 € (-5,32 %)     SCHNEIDER ELECTRIC 285.650 € (+1,04 %)     PROSUS 42.490 € (+1,46 %)     SAINT GOBAIN 81.700 € (+1,82 %)     KALRAY 8.500 € (+0,95 %)     AIRBUS 189.560 € (+0,56 %)     HEINEKEN 66.660 € (-0,09 %)     CSG 16.474 € (-3,41 %)     AIR FRANCE -KLM 10.595 € (+2,81 %)     SOCIETE GENERALE 71.050 € (+1,50 %)     AIR LIQUIDE 178.220 € (-1,14 %)     ADYEN 961.100 € (+0,37 %)     CAPGEMINI 104.100 € (-0,81 %)     ASML HOLDING 1 328.400 € (+1,79 %)     DASSAULT SYSTEMES 19.695 € (-0,38 %)     HERMES INTL 1 716.000 € (+2,66 %)     ING GROEP N.V. 25.865 € (+1,31 %)     VOPAK 44.340 € (+0,45 %)     BNP PARIBAS ACT.A 94.180 € (+0,82 %)     SONAE 1.956 € (-0,31 %)     GTT 207.600 € (-1,42 %)     PHARMING GROUP 1.160 € (-16,85 %)     L'OREAL 374.050 € (+0,17 %)     STMICROELECTRONICS 48.720 € (+0,45 %)     ALSTOM 17.715 € (+0,77 %)     GALP ENERGIA-NOM 18.965 € (-1,71 %)     BIOSYNEX 0.810 € (+10,05 %)     THALES 240.600 € (-0,17 %)     NANOBIOTIX 36.120 € (+4,09 %)     SANOFI 73.600 € (-1,39 %)     TOTALENERGIES 75.820 € (-1,21 %)     LEGRAND 165.200 € (+3,19 %)     EDP 4.389 € (+0,87 %)     MEDINCELL 26.580 € (+0,23 %)     KPN KON 4.570 € (-0,80 %)     COFACE 16.300 € (+0,80 %)     ACCOR 45.640 € (+2,33 %)     RENAULT 31.320 € (+2,02 %)     LVMH 484.950 € (+2,31 %)     HAFFNER ENERGY 0.120 € (+10,09 %)     ADOCIA 5.215 € (+8,56 %)     CHRISTIAN DIOR 456.400 € (+2,06 %)     EUROFINS SCIENT. 59.860 € (-0,23 %)     Vusion 124.200 € (-0,16 %)     SAFRAN 300.850 € (+1,40 %)     FORVIA 10.730 € (+2,39 %)     AXA 41.720 € (-0,19 %)     REXEL 38.830 € (+1,01 %)  
News Réglementées
15/04/2026 12:00

Original-Research: CENIT AG (von GBC AG): Buy

Original-Research: CENIT AG - from GBC AG

15.04.2026 / 12:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of GBC AG to CENIT AG

Company Name:CENIT AG
ISIN:DE0005407100
 
Reason for the research:Research Study (Anno)
Recommendation:Buy
Target price:EUR 16.00
Target price on sight of:31.12.2026
Last rating change:
Analyst:Cosmin Filker; Marcel Goldmann

Focus on improving profitability likely to characterise the current financial year, earnings turnaround in sight

In the 2025 financial year, CENIT AG achieved a slight increase in revenue of 1.1% to €209.51 million (previous year: €207.33 million), thereby slightly exceeding the company forecast adjusted at the half-year 2025. Growth was primarily driven by inorganic expansion through the first-time full consolidation of Analysis Prime, whilst organic growth saw a slight decline. Difficult market conditions, particularly in the automotive and mechanical engineering sectors, which are key for the company, prevented a stronger revenue performance.

At the product group level, there is a clear structural shift towards higher-margin revenue streams. Revenue from proprietary software once again showed particularly dynamic growth, rising by 11.2% to €21.42 million (previous year: €19.27 million) and recording a significant growth spurt, particularly in the fourth quarter. The consulting and services business also grew by 2.4% to €87.41 million (previous year: €85.34 million), attributable in part to the contribution from Analysis Prime. By contrast, revenue in the traditionally high-volume third-party software business fell by 2.3% to €100.26 million, reflecting the continued reluctance to invest.

Despite the gross profit margin improving to 60.1% (previous year: 58.8%), earnings performance was significantly impacted by exceptional expenses of around €4.0 million incurred as part of the “Project Performance” restructuring programme. In addition, Analysis Prime reported a net loss after tax of €2.0 million. Consequently, EBITDA fell significantly to €12.28 million (previous year: €17.26 million). However, the momentum during the year is to be viewed positively, as initial efficiency gains were already becoming apparent, particularly in the second half of the year. Depreciation and amortisation (including impairment losses on Analysis Prime’s customer base) further weighed on EBIT, which fell to €0.31 million (previous year: €7.38 million). Worth noting is the sharp rise in operating cash flow to €14.13 million (previous year: €10.34 million), which was used to significantly reduce bank debt.

The basis for future development is a significantly increased order book (+15.3% to €93.5 million), a stronger focus on larger and higher-margin projects, and an optimised sales structure. In addition, structural trends such as cloud migration, rising recurring revenue and the growing importance of AI-supported solutions are providing further growth momentum. At the same time, management remains cautious due to external uncertainties and continued volatility in investment appetite. For the current financial year, CENIT AG anticipates revenue of at least €210 million and EBITDA of at least €18 million.

Our estimates are slightly higher, and we expect revenue to rise to €214.74 million and a significant improvement in EBITDA to €19.13 million. For the following years, we anticipate accelerated revenue growth of 6% per annum and a gradual expansion of the EBITDA margin to over 10%. This will be driven by economies of scale, the elimination of one-off effects and efficiency gains.

Management Change at CENIT AG: CEO Peter Schneck is stepping down from his position effective April 30, 2026, by mutual agreement with the Supervisory Board, after having played a key role since 2022 in driving the company’s international expansion and growth strategy (including eight acquisitions) as well as increasing revenue to €209.5 million. Effective May 1, 2026, Martin Thiel, the current COO, will assume the CEO position, ensuring continuity in the strategic realignment. At the same time, the company is placing greater emphasis on areas such as profitability, consolidation, and operational excellence, particularly in light of the planned transition to the Scale segment of the stock exchange.

Using the DCF valuation model, we have determined a target price of €16.00 (previously: €15.00). We maintain our BUY rating.



You can download the research here: 20260415_CENIT_Anno_engl

Contact for questions:
Contact for questions:
GBC AG
Halderstraße 27
86150 Augsburg
0821 / 241133 0
research@gbc-ag.de
++++++++++++++++
Disclosure of potential conflicts of interest pursuant to Section 85 WpHG
and Art. 20 MAR The company analysed above has the following potential
conflict of interest: (5a,6a,7,11); A catalogue of potential conflicts of
interest can be found at: https://www.gbc-ag.de/de/Offenlegung.htm
+++++++++++++++
Date (time) Completion: 15.04.2026 (08:12 am)
Date (time) first transmission: 15.04.2026 (12:00 pm)


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2308510  15.04.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière